Antiparasitic drug shows promise as an early treatment for mild-to-moderate COVID-19

Early treatment with the FDA-approved antiparasitic drug nitazoxanide prevents mild or moderate COVID-19 symptoms from progressing to severe illness and hospitalization, a clinical study co-led by USF Health’s […]